FDA stem cell

Fat stem cells are drugs & more: FDA final guidances point to a new era

FDA-stem-cell-policy-flow-chart-e1510854295902

Are fat stem cells a drug? Today the FDA definitively indicated “yes” without leaving much of any room for exceptions on this question. This morning the FDA made a major announcement on stem cell policy regarding its current thinking on oversight of regenerative medicine and issued four guidances, including two each in final and in …

Fat stem cells are drugs & more: FDA final guidances point to a new era Read More »

Six questions as FDA takes new shot at stem cell clinics

FDA-draft-guidance

The FDA issued a historic statement today promising to more clearly define its regulatory policies on stem cell therapies and to take strong action on some stem cell clinics that it views as “bad actors”. I’ve never the FDA use such clear-cut language before. I give big kudos to new FDA Commissioner Scott Gottlieb. It already …

Six questions as FDA takes new shot at stem cell clinics Read More »

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics

Jonathan-Kimmelman-FDA-e1473490111453

The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here. In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics. Jonathan Kimmelman from McGill University got the afternoon going …

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics Read More »